Medicine and Dentistry
Surgery
100%
Bone Metastasis
90%
Neoplasm
90%
Radiation Therapy
72%
Metastatic Carcinoma
70%
Soft Tissue Sarcoma
67%
Pelvis
65%
Diseases
58%
Osteosarcoma
57%
Connective Tissue Cancer
47%
Recurrent Disease
47%
Malignant Neoplasm
42%
Overall Survival
40%
Clear Cell Renal Cell Carcinoma
39%
Hemipelvectomy
37%
Synovial Sarcoma
36%
Chondrosarcoma
31%
Primary Tumor
31%
Ewing Sarcoma
31%
Osteoblast
30%
Hazard Ratio
25%
Surgeon
25%
Cancer Surgery
25%
Systematic Review
24%
Musculoskeletal Tumor
23%
Limb Salvage
21%
Spinal Cord Tumor
21%
Implant
20%
Fibula Graft
20%
Infection
20%
Prostate Cancer
19%
Neck
18%
Pediatrics
18%
Free Tissue Graft
18%
Limb
17%
Cancer
16%
Spine Surgery
16%
Local Therapy
15%
Pathologic Fracture
15%
In Vitro
15%
Lung Metastasis
15%
Prosthetics
15%
Cumulative Incidence
15%
Surgical Planning
15%
Patient-Reported Outcome
15%
Wound
14%
Odds Ratio
14%
Osteolysis
14%
Cancer Cell
14%
Magnetic Resonance Imaging
14%
Programmed Cell Death
13%
Surgical Technique
13%
Retrospective Study
13%
Intramedullary Nailing
13%
Survival Rate
13%
Multimodality Cancer Therapy
12%
Upper Limb
12%
Local Recurrence Free Survival
12%
Dedifferentiated Liposarcoma
12%
Osteocyte
12%
Desmoid Tumor
12%
Surgical Oncology
12%
Psoas Muscle
12%
Gap Junction
12%
Analgesia
12%
Cabozantinib
12%
Distal Femur
12%
Sacrum
12%
Interleukin 11 Receptor
12%
Preoperative Radiotherapy
12%
Oncology
12%
Adolescence
12%
Femur Fracture
11%
Bone Marrow Stromal Cell
11%
Lymph Node Metastasis
11%
Prosthesis
11%
Diagnosis
11%
Disease Specific Survival
10%
Wide Local Excision
10%
Osteotomy
10%
Allograft
10%
Kaplan Meier Method
10%
Nonunion
10%
Quality of Life
10%
Oncologist
10%
Humerus
9%
Nail
9%
Interleukin 11
9%
Localized Disease
9%
Cementation
9%
Orthopedics
9%
Treatment Response
9%
Biopsy Technique
9%
Prosthesis Loosening
8%
Proportional Hazards Model
8%
Amputation
8%
Bone Atrophy
8%
Reoperation
8%
Muscle Strength
8%
Meta-Analysis
8%
Keyphrases
Soft Tissue Sarcoma
43%
Synovial Sarcoma
42%
Osteosarcoma
37%
Combined Modality Therapy
26%
Overall Survival
25%
Radiation Therapy
23%
Confidence Interval
23%
Hazard Ratio
22%
Tumor
22%
Metastasis
21%
Bone Metastasis
19%
Oncologic
19%
Local Recurrence
19%
Chemotherapy
19%
Local Control
18%
Ewing Sarcoma
18%
Neoadjuvant
18%
Renal Cell Carcinoma
18%
Pediatric
18%
Therapeutic Strategies
17%
Local Therapy
14%
Head-and-neck
14%
Limb Salvage
14%
Older Adults
14%
Sarcoma
13%
Lung Metastasis
13%
Meta-analysis
13%
Osteosarcoma Cells
12%
Local Recurrence-free Survival
12%
Interleukin-11 Receptor
12%
Enhancer of Zeste Homolog 2 (EZH2)
12%
Extraskeletal Osteosarcoma
12%
Human Mesenchymal Stem Cells (hMSCs)
12%
Desmoid Tumor
12%
Signaling Axis
12%
Extremity Reconstruction
12%
High Risk
11%
Clinical Outcomes
11%
Spine
10%
Surgical Resection
10%
Disease-specific Survival
10%
Progression-free Survival
10%
Odds Ratio
9%
Lower Extremity
9%
Tumor Size
9%
Clinical Characteristics
9%
Median Time
9%
Metastatic Disease
8%
Risk Factors
8%
Systematic Literature Review
8%
Apoptosis
7%
Preoperative Chemotherapy
7%
Local Tumor Control
7%
Gemcitabine
7%
Localized Disease
7%
TP53 mutation
7%
Clinical Activity
7%
SS18
7%
Phase II Study
7%
Treatment Strategy
7%
Chondrosarcoma
7%
Clinical Practice
7%
Systematic Meta-analysis
7%
Surgical Technique
7%
Multivariate Analysis
7%
Osteolytic
6%
Denosumab
6%
Trunk
6%
Radiotherapy
6%
Quality of Life
6%
Oncological Outcomes
6%
Pediatric Patients
6%
Surgery Therapy
6%
Retrospective Review
6%
ACR Appropriateness Criteria
6%
Treatment Resistance
6%
Patellar Height
6%
Sentinel Lymph Node Biopsy
6%
Gap Junction
6%
Virtual Cutting
6%
Therapeutic Approaches
6%
Cryoablation
6%
Epidural Infection
6%
Cadherin-11
6%
Tumor Prosthesis
6%
Two-stage Revision
6%
Recurrent Chordoma
6%
Implant Retention
6%
Extraskeletal Ewing Sarcoma
6%
Small nucleolar RNA (snoRNA)
6%
Evidence-based Approach
6%
Bilateral Asymmetry
6%
Immune Checkpoint Blockade
6%
Prognostic Indicator
6%
Mineralization Conditions
6%
Pigmented Villonodular Synovitis
6%
Free Flap
6%
Residual Limb Length
6%
Neurological Deterioration
6%
Walking Function
6%